Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Broad Center for Mendelian Genomics, |
RCV002790031 | SCV003761400 | likely pathogenic | Warburg micro syndrome 1 | 2023-01-25 | criteria provided, single submitter | curation | The heterozygous p.Leu798ArgfsTer7 variant in RAB3GAP1 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (NC_000002.12: 135162318_135164794del), in one individual with Warburg Micro syndrome-1. This individual also carried a likely pathogenic variant (NC_000002.12: 135162318_135164794del), however, the phase of these variants are unknown at this time. The p.Leu798ArgfsTer7 variant in RAB3GAP1 has not been previously reported in individuals with Warburg Micro syndrome-1 but has been identified in 0.0009% (1/113124) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs1558805679). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 798 and leads to a premature termination codon 7 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the RAB3GAP1 gene is an established disease mechanism in autosomal recessive Warburg Micro syndrome-1. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for Warburg Micro syndrome-1. ACMG/AMP Criteria applied: PVS1, PM2_Supporting (Richards 2015). |